CYTOMX THERAPEUTICS INC. |
USA |
Gesundheit |
US23284F1057 / A14158 |
6C1 (Frankfurt) / CTMX (NASDAQ) |
FRA:6C1, ETR:6C1, 6C1:GR, NASDAQ:CTMX |
- |
https://cytomx.com/ |
CytomX Therapeutics Inc. is a clinical-stage bioph..
>Volltext.. |
531.72 Mio. EUR |
402.88 Mio. EUR |
121.64 Mio. EUR |
38.53 Mio. EUR |
41.37 Mio. EUR |
0.49 EUR |
5.94 Mio. EUR |
42.28 Mio. EUR |
-66.75 Mio. EUR |
4.03 |
7.3% |
293.56% |
- |
- |
- |
- |
CYTOMX |
21.10.25 |
|